The possible role of adrenomedullin in the etiology of gestational hypertension and preeclampsia;Możliwy udział adrenomedulliny w etiologii nadciśnienia ciążowego oraz stanu przedrzucawkowego

Ginekologia Polska

Volumn 82, Issue 3, 2011, Pages 178-184

  Adrianna, Boć Zalewska ^a   Agnieszka, Seremak Mrozikiewicz ^a   Magdalena, Barlik ^a   Grazyna, Kurzawińska ^a   Krzysztof, Drews ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adrenomedullin; Gene polymorphism; Gestational hypertension; Preeclampsia

Indexed keywords

EID: 79955395585     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kitamura K, Kato J, Kawamoto M, et al.. The intermediate form of glycine- extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun. 1999, 244, 551-555.
2. Pridjian G, Puschett J. Preeclampsia: Part 2 experimental and genetic considerations. Obstet Gynecol Surv. 2002, 57, 619-640.
3. Tanaka M, Kitamura K, Ishizaka Y, et al.. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern Med. 1995, 34, 728-733.
4. Isumi Y, Shoji H, Sugo S, et al.. Regulation of adrenomedullin production in rat endothelial cells. Endocrinology. 1998, 139, 838-846.
5. Li H, Dakour J, Kaufman S, [et al]. Adrenomedullin is decreased in preeclampsia because of failed response to epidermal growth factor and impaired syncytialization. Hypertension. 2003, 42, 895-900.
6. Lewis L, Smith M, Yandle T, et al.. Adrenomedullin (1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption and storage. Clin Chem. 1998, 44, 571-577.
7. Mello G, Parretti E, Marozio L, et al.. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale case-controlled study. Hypertension. 2005, 46, 1270-1274.
8. Nishikimi T, Horio T, Kohmoto Y, et al.. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J Hypertens. 2001, 19, 765-773.
9. Thadhani R, Ecker J, Mutter W, et al.. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension. 2004, 43, 988-992.
10. Ishimitsu T, Ono H, Minami J, et al.. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther. 2006, 111, 909-927.
11. Kato J, Tsuruda T, Kita T, et al.. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol. 2005, 25, 2480-2487.
12. Kohno M, Kano H, Horio T, et al.. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension. 1995, 25, 1185-1190.
13. Di Iorio R, Marinoni E, Scavo D, et al.. Adrenomedullin in pregnancy. Lancet. 1997, 349, 328.
14. Di Iorio R, Marinoni E, Letizia C, et al.. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension. 1998, 32, 758-763.
15. Jerat S, Morrish D, Davidge S, Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension. 2001, 37, 227-231.
16. Than N, Sumegi B, Than G, et al.. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein. Placenta. 1999, 20, 703-710.
17. Macara L, Kingdom J, Kaufmann P. Control of the fetoplacental circulation. Fetal Matern Med Rev. 1993, 5, 167-179.
18. Ishimitsu T, Hosoya K, Tsukada K, et al.. Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension. Hypertension. 2001, 38, 9-12.
19. Kobayashi Y, Nakayama T, Sato N, et al.. Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertension Res. 2005, 28, 229-236.
20. Li Y, Staessen J, Li LH, et al.. Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int. 2006, 69, 1153-1158.
21. Boć-Zalewska A. Adrenomedullina w nadciśnieniu cia{ogonek}żowym oraz w stanie przedrzucawkowym. Rozprawa doktorska. Poznań: Uniwersytet Medyczny im. Karola Marcinkowskiego, 2010, 1-114.
22. Lauria M, Standley C, Sorokin Y, et al.. Adrenomedullin levels in normal and preeclamptic pregnancy at term. J Soc Gynecol Investig. 1999, 6, 318-321.
23. Hoshimoto K, Hayashi M, Ohkura T. Mature adrenomedullin concentrations in plasma during pregnancy. J Matern Fetal Neonatal Med. 2002, 11, 126-129.
24. Kanenishi K, Kuwabara H, Ueno M, et al.. Immunohistochemical adrenomedullin expression is decreased in the placenta from pregnancies with pre-eclampsia. Pathol Int. 2000, 50, 536-540.
25. Senna A, Zedan M, el-Salam G, el-Mashad A. Study of plasma adrenomedullin level in normal pregnancy and preeclampsia. Medscape J Med. 2008, 10, 29-37.
26. Ulman-Włodarz I, Kokot F, Irzyniec T. Adrenomedullin in physiological pregnancy and preeclampsia. Akt Nefrol. 2003, 1, 8-12.
27. Hata T, Miyazaki K, Matsui K. Decreased circulating adrenomedullin in pre-eclampsia. Lancet. 1997, 350, 1600.
28. Kanenishi K, Kuwabara H, Ueno M, et al.. Change of adrenomedullin concentrations in plasma and amniotic fluid and human placental adrenomedullin expression with advancing gestation. Placenta. 2001, 22, 244-250.
29. Sano M, Kuroi N, Nakayama T, et al.. Association study of calcitonine-receptor-like receptor gene in essential hypertension. Am J Hypertension. 2005, 18, 403-408